Literature DB >> 32031030

Richter's transformation in patients with chronic lymphocytic leukaemia: a Nationwide Epidemiological Study.

Yasmin Ben-Dali1, Mariam H Hleuhel1, Caspar da Cunha-Bang1,2, Christian Brieghel1, Christian B Poulsen2, Erik Clasen-Linde3, Hans H N Bentzen4, Henrik Frederiksen5, Ilse Christiansen6, Linda H Nielsen7, Lisbeth Enggaard8, Marie Helleberg9, Michael Clausen10, Mikael Frederiksen11, Robert S Pedersen12, Carsten U Niemann1, Michael A Andersen1.   

Abstract

Richter's transformation (RT) refers to the development of an aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL). Approximately, 2-10% of patients with CLL develop RT, most often as diffuse large B-cell lymphoma. To assess the incidence of RT, we examined risk factors for RT and death among patients with RT in a nationwide CLL cohort (from 2008 to 2016). Among 3772 patients, 113 had biopsy-proven RT. With a median follow-up of 4.3 years, the 5-year cumulative incidence of RT was 2.8%. Advanced Binet stage (B/C) (p<.001), unmutated IGHV (p<.001), and del(17p) (p<.001) were independently associated with risk of developing RT. Half of the patients with RT (49%) were treatment-naïve prior to transformation and demonstrated longer survival after RT compared to patients previously treated for CLL (6.1 vs. 2.8 years, p=.03). Whether this finding could be explained by a higher proportion of clonally unrelated RT among treatment-naïve patients, remain to be addressed.

Entities:  

Keywords:  Chronic lymphocytic leukemia; Hodgkin lymphoma; Richter’s transformation; diffuse large B-cell lymphoma; prognostication

Mesh:

Year:  2020        PMID: 32031030     DOI: 10.1080/10428194.2020.1719092

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  3 in total

1.  Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.

Authors:  Alex F Herrera; Kwang Woo Ahn; Carlos Litovich; Yue Chen; Amer Assal; Qaiser Bashir; Ruthee-Lu Bayer; Melanie Coleman; Zachariah DeFilipp; Nosha Farhadfar; Matthew Greenwood; Theresa Hahn; Mitchell Horwitz; Caron Jacobson; Samantha Jaglowski; Sylvie Lachance; Amelia Langston; Bassam Mattar; Richard T Maziarz; Joseph McGuirk; Mohammad A H Mian; Sunita Nathan; Adrienne Phillips; Kevin Rakszawski; Henrik Sengeloev; Shalini Shenoy; Robert Stuart; Craig S Sauter; Mohamed A Kharfan-Dabaja; Mehdi Hamadani
Journal:  Blood Adv       Date:  2021-09-28

2.  Apoptotic Blocks in Primary Non-Hodgkin B Cell Lymphomas Identified by BH3 Profiling.

Authors:  Ryan N Rys; Claudia M Wever; Dominique Geoffrion; Christophe Goncalves; Artin Ghassemian; Eugene Brailovski; Jeremy Ryan; Liliana Stoica; Josée Hébert; Tina Petrogiannis-Haliotis; Svetlana Dmitrienko; Saul Frenkiel; Annette Staiger; German Ott; Christian Steidl; David W Scott; Pierre Sesques; Sonia Del Rincon; Koren K Mann; Anthony Letai; Nathalie A Johnson
Journal:  Cancers (Basel)       Date:  2021-02-28       Impact factor: 6.639

3.  Richter Transformation: Clinical Manifestations, Evaluation, and Management.

Authors:  Melanie Douglas
Journal:  J Adv Pract Oncol       Date:  2022-07-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.